Industry Improving On LMIC Drug Access Plans But Tropical Disease R&D Lacking
Argues Access To Medicine Foundation
Executive Summary
The non-profit Access To Medicine Foundation’s latest report shows big pharma is making progress on drug access plans as new non-exclusive voluntary licences help facilitate sustainable supply, but there is still not enough R&D for tropical diseases.